Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4756872
Max Phase: Preclinical
Molecular Formula: C60H113NNa4O20S3
Molecular Weight: 1268.78
Molecule Type: Unknown
Associated Items:
ID: ALA4756872
Max Phase: Preclinical
Molecular Formula: C60H113NNa4O20S3
Molecular Weight: 1268.78
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCCCCCCCCCCCCCCCCCCCCOCC(C)(COCCCCCCCCCCCCCCCCCCCCCC)CO[C@]1(C(=O)[O-])C[C@H](OS(=O)(=O)[O-])[C@@H](NC(C)=O)[C@H]([C@H](O)[C@@H](COS(=O)(=O)[O-])OS(=O)(=O)[O-])O1.[Na+].[Na+].[Na+].[Na+]
Standard InChI: InChI=1S/C60H117NO20S3.4Na/c1-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-37-39-41-43-45-75-49-59(4,50-76-46-44-42-40-38-36-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-2)51-77-60(58(64)65)47-53(80-83(69,70)71)55(61-52(3)62)57(79-60)56(63)54(81-84(72,73)74)48-78-82(66,67)68;;;;/h53-57,63H,5-51H2,1-4H3,(H,61,62)(H,64,65)(H,66,67,68)(H,69,70,71)(H,72,73,74);;;;/q;4*+1/p-4/t53-,54+,55+,56+,57+,60+;;;;/m0..../s1
Standard InChI Key: BJFHPPAPSKHEMG-SNJYSJBGSA-J
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1268.78 | Molecular Weight (Monoisotopic): 1267.7331 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. de Castro S,Ginex T,Vanderlinden E,Laporte M,Stevaert A,Cumella J,Gago F,Camarasa MJ,Luque FJ,Naesens L,Velazquez S. (2020) N-benzyl 4,4-disubstituted piperidines as a potent class of influenza H1N1 virus inhibitors showing a novel mechanism of hemagglutinin fusion peptide interaction., 194 [PMID:32220685] [10.1016/j.ejmech.2020.112223] |
Source(1):